Biopharma is set to lose two of the industry’s rare women CEOs—GSK’s Emma Walmsley and Merck KGaA's Belén Garijo—leaving a dearth of women-helmed large life sciences companies. The Life Sciences are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback